Global Blood Gas Monitoring Products Market $6.8 Billion by 2029

The global market for blood gas monitoring products expected to attain $6.8 billion by 2029, growing at a CAGR of 5.7% over the forecast period, driven by increasing prevalence of chronic and infectious diseases, growing elderly population, and, technological advancements.

• Pulse oximetry, capnometry and transcutaneous blood gas measurement have been used for many years to assess gas exchange continuously and non-invasively. However, these non-invasive methods cannot fully replace arterial Po₂ (Pa_O2), arterial Pco₂ (Pa_CO2), and arterial pH (pHa) analyses in the clinical setting because of their significant limitations.

Blood gas monitoring involves an estimation of the partial pressure of oxygen (pO2) and partial pressure of carbon dioxide (pCO2) in the blood and the pH of blood. Blood gas analysis provides critical information to healthcare providers that assists in the diagnosis and treatment of a variety of metabolic and respiratory disorders.

• Blood gas analysis can be performed not only in the central or core laboratory, but in satellite laboratories or with portable devices at the point of care (POC) in critical care areas such as the emergency department, neonatal and adult medical intensive care units, surgical intensive care units, and the operating room.

The global blood gas monitoring devices market research report provides market size (Revenue $million 2019 to 2029), market share analysis, growth trends and forecast (CAGR%, 2023 to 2029).

The global market for blood gas monitoring systems segmented by product (point-of-care blood gas analyzers, laboratory blood gas analyzers, arterial blood gas sampling kits, pulse oximeters, capnography systems / end-tidal carbon dioxide (EtCO2) monitoring products), by type / modality (handheld, portable, benchtop), by end user (ambulatory surgical centers, hospitals, clinics) and geography.

• Based on the products, the point-of-care (POC) gas analyzers segment expected to grow at a modest rate during the forecast period, due to its faster and less costly test results; whereas the capnography systems segment anticipated to register the fastest growth rate over the forecast period.
  • There has been an increase in demand for capnography monitoring systems due to rising prevalence of diseases such as sleep apnea and respiratory diseases (asthma, chronic obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension, etc.).
• Demand for reliable, accurate, high-quality pulse oximetry devices driven by the rise of chronic diseases, a growing elderly population prone to asthma, heart disease, sleep apnea and COPD.
  • The pulse oximetry systems are also being used outside of hospitals, such as for continuous home health-care monitoring of patients with chronic respiratory conditions.
    • Technological advances that lead to increasing accuracy and reliability of results are generating greater confidence in the use of pulse oximeters, stimulating sales.
      • Pulse oximetry has been recommended for the continuous monitoring of patients’ oxygenation, respiration and ventilation status by the Joint Commission, the Anesthesia Patient Safety Foundation, the American Society of Anesthesiologists and the American Society of Pain Management.
• The arterial blood gas (ABG) analyses are essential to monitor gas exchange in critically ill patients and during anesthesia for major surgery. Usually, arterial blood samples are drawn intermittently and analyzed in a central laboratory or by a point-of-care blood gas analyzer.
  • Arterial blood gas interpretation is best approached systematically.  Interpretation leads to an understanding of the degree or severity of abnormalities, whether the abnormalities are acute or chronic, and if the primary disorder is metabolic or respiratory in origin.  
• The collection and analysis by portable or standard blood gas machines at or near the point of care minimizes the time needed to obtain and report laboratory values, which facilitates timely evaluation of results and prompt intervention.
  • Modern analyzers come in a variety of sizes from hand-held to portable desktop systems, which are more user friendly, more automated, and require less technical expertise and maintenance by the end user compared with earlier analyzers.

The global blood gas monitoring products market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

In addition, the global market for blood gas monitoring systems report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.  The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

• The top three competitors in the blood gas monitoring products market are Medtronic Minimally Invasive Therapies, Masimo, Inc. and Abbott Laboratories, Inc., accounting for majority of the total market.

Other key players operating in the global blood gas monitoring devices market and profiled in this report include Becton, Dickinson and Company, GE Healthcare, Nonin Medical, Inc., Philips Healthcare / Koninklijke Philips N.V., Radiometer / Danaher Corporation, Roche Diagnostics / F. Hoffmann-La Roche AG, Siemens Healthineers AG, Smiths Medical, Inc., Vyaire Medical, Inc., and Welch Allyn, Inc. (Hill-Rom).

• Product
  • Point-of-Care (POC) Blood Gas Analyzers
  • Laboratory Blood Gas Analyzers
  • Arterial Blood Gas (ABG) Sampling Kits
  • Pulse Oximeters
  • Capnography Systems / End-Tidal Carbon Dioxide (EtCO2) Monitoring Products
• Type / Modality
  • Handheld
  • Portable
  • Benchtop
• End User
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals
  • Clinics
• Geography
  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
  • Asia Pacific (Japan, China, India, Rest of APAC)
  • Latin America (Brazil, Mexico, Rest of LA)
  • Rest of the World
• Company Profiles
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • GE Healthcare
  • Masimo, Inc.
  • Medtronic plc
  • Nonin Medical, Inc.
  • Philips Healthcare / Koninklijke Philips N.V.
  • Radiometer / Danaher Corporation
  • Roche Diagnostics (Roche Holding AG)
  • Siemens Healthineers AG
  • Smiths Medical, Inc.
  • Vyaire Medical, Inc.
  • Welch Allyn, Inc. (Hill-Rom)

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/blood-gas-monitoring-systems-market/

Related publications:

• Blood Gas Monitoring Systems Market by Product (Point-of-Care Blood Gas Analyzers, Laboratory Blood Gas Analyzers, Arterial Blood Gas Sampling Kits, Pulse Oximeters, Capnography Systems / End-Tidal Carbon Dioxide Monitoring Products), by Type (Handheld, Portable, Benchtop), by End User (Ambulatory Surgical Centers, Hospitals, Clinics) and Forecast 2022-2029
• Veterinary Gas Analyzers Market by Modality (Portable Analyzers and Handheld Analyzers); by Animal (Companion Animals, Poultry & Dairy Animals, Livestock Animals, and Others); by End User (Veterinary Clinics, Veterinary Laboratories, Research Laboratories, and Others) and Forecast 2022-2029
• Global Medical Gas Supply and Equipment Market $6.7 Billion by 2029
• Mobile Health Care (mHealth) Market by Product (Blood Pressure, Blood Glucose, Cardiac Rhythm, Pulse, Sleep Apnea, and Multi-Parameter Monitors) and Forecast 2022-2029
• Mobile Medical Devices Market by Product (Blood Pressure Monitors, Cardiac Monitors, Glucose Monitors, Multi-Parameter Monitors, Pulse Oximeters, Sleep Apnea Monitors) and Forecast 2022-2029